Search results for "Breast Cancer"
New tool makes it easy to add crucial family history to EHRs
Electronic medical records are slowly pushing out the family history, eliminating valuable diagnostic information. But a free tool offers an easy way to restore important details to a clinician's files.
https://immattersacp.org/archives/2009/05/genomics.htm
1 May 2009
MKSAP Quiz: dietary counseling for class II obesity
ACIP recommends seasonal flu vaccine for almost everyone
https://immattersacp.org/weekly/archives/2010/03/02/4.htm
2 Mar 2010
A little girl's dream: The path to becoming ACP President
ACP's outgoing President reflects on her life, her career, the past year, and the lessons it has taught her.
https://immattersacp.org/archives/2021/04/a-little-girls-dream-the-path-to-becoming-acp-president.htm
1 Apr 2021
Highest-risk childhood cancer survivors don't follow recommended screenings
Highest-risk childhood cancer survivors don't follow recommended screeningsACGME approves final duty hour and supervision standards
https://immattersacp.org/weekly/archives/2010/10/05/1.htm
5 Oct 2010
FDA updates boxed warnings for rosiglitazone, other drugs
The latest drug alerts and approvals.
https://immattersacp.org/archives/2008/01/fda.htm
1 Jan 2008
Screen childhood cancer survivors for digestive, genitourinary neoplasms in adulthood
Childhood cancer survivors who develop subsequent primary neoplasms in adulthood are most likely to experience digestive and genitourinary cancers, so screening should focus on these two areas to reduce overall incidence.
https://immattersacp.org/weekly/archives/2011/06/07/5.htm
7 Jun 2011
New warning for testosterone, approval for inhaled insulin
This update covers a revised warning on testosterone products about the risk of venous thromboembolism, and approval of a fast-acting inhaled insulin to treat diabetes in adults.
https://immattersacp.org/archives/2014/09/fda.htm
1 Sep 2014
Modeling study finds benefit in personalized mammogram schedules
Personalized mammography schedules based on women's individual risk factors could be more beneficial and cost-effective than generalized recommendations, according to a new modeling study.
https://immattersacp.org/weekly/archives/2011/07/12/1.htm
12 Jul 2011
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Research reveals reasons underlying patient no-shows
It's the $19 million-dollar question: How do you get your patients to show up for their appointments? Easy-to-follow tips can increase practice revenue.
https://immattersacp.org/archives/2009/02/no-shows.htm
1 Feb 2009